Another report proposed that the knockdown of IRE1α suppressed the proliferation of colon cancer cells in vitro and xenograft growth in vivo through repressing the expression of β-catenin, a key factor that drives colonic tumorigenesis, thereby activating eIF2α signaling. The gene discussed is ERN1; the disease is colonic neoplasm.